Vimarsana
Biggest News Aggregation in the World

Page 13 - Morphic Holding News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Morphic Holding. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Morphic Holding Today - Breaking & Trending Today

Morphic Holding, Inc. (NASDAQ:MORF) General Counsel Sells $228,234.06 in Stock - Vimarsana News

Morphic Holding, Inc. (NASDAQ:MORF) General Counsel Sells $228,234.06 in Stock

Morphic Holding, Inc. (NASDAQ:MORF – Get Rating) General Counsel William Devaul sold 3,802 shares of Morphic stock in a transaction dated Tuesday, May 23rd. The shares were sold at an average price of $60.03, for a total transaction of $228,234.06. Following the sale, the general counsel now owns 21,194 shares of the company’s stock, valued […]

Serial biotech founder Tim Springer on investing in startups and democratizing antibody research - Vimarsana News

Serial biotech founder Tim Springer on investing in startups and democratizing antibody research

BioPharma

Robert E. Farrell, Jr. Sells 10,000 Shares of Morphic Holding, Inc. (NASDAQ:MORF) Stock - Vimarsana News

Robert E. Farrell, Jr. Sells 10,000 Shares of Morphic Holding, Inc. (NASDAQ:MORF) Stock

Morphic Holding, Inc. (NASDAQ:MORF – Get Rating) CAO Robert E. Farrell, Jr. sold 10,000 shares of the business’s stock in a transaction that occurred on Tuesday, May 23rd. The shares were sold at an average price of $60.00, for a total transaction of $600,000.00. Following the transaction, the chief accounting officer now directly owns 23,708 […]

Inside Scoop: 10 Mid-Cap Stocks with Recent Insider Purchases - Vimarsana News

Inside Scoop: 10 Mid-Cap Stocks with Recent Insider Purchases

In this article, we will take a look at the 10 mid-cap stocks that insiders have been buying lately.

Morphic (MORF) – Investment Analysts' Weekly Ratings Changes - Vimarsana News

Morphic (MORF) – Investment Analysts' Weekly Ratings Changes

Several brokerages have updated their recommendations and price targets on shares of Morphic (NASDAQ: MORF) in the last few weeks: 5/8/2023 – Morphic was upgraded by analysts at TheStreet from a “d+” rating to a “c” rating. 4/26/2023 – Morphic had its price target raised by analysts at BMO Capital Markets from $83.00 to $106.00. […]

Source: wkrb13.com